Ivo Lorenz, Ph.D., is Head of Biologics, Deerfield Discovery and Development, and joined Deerfield in 2021. Prior to Deerfield, Dr. Lorenz was Vice President, Biologics at the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI). Before the Tri-I TDI, he held group leader positions in R&D at Boehringer Ingelheim Pharmaceuticals and at the International AIDS Vaccine Initiative (IAVI). Dr. Lorenz holds a Ph.D. in Biochemistry and a M.Sc. in Biochemistry and Molecular Biology from the Swiss Federal Institute of Technology in Zurich.